Network origin in Myra Rosario Herrle first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
122
| Public Company | Pharmaceuticals: Major | 122 |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ.
74
| Subsidiary | Pharmaceuticals: Major | 74 |
43
| Public Company | Pharmaceuticals: Major | 43 |
26
| Public Company | Pharmaceuticals: Major | 26 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Myra Rosario Herrle via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
POINT Biopharma, Inc. (United States)
 POINT Biopharma, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Part of POINT Biopharma Global, Inc., POINT Biopharma, Inc. (United States) develops next-generation radioligand therapies for the treatment of cancer. The company is based in Indianapolis, IN. Joe McCann has been the CEO of the company since 2019. POINT Biopharma, Inc. (United States was acquired by Therapeutics Acquisition Corp. on June 30, 2021 for $578.95 million. | Miscellaneous Commercial Services | Chairman Director/Board Member Chief Tech/Sci/R&D Officer Director/Board Member Chief Executive Officer Chief Operating Officer Director/Board Member Director of Finance/CFO Corporate Officer/Principal | |
Genelabs Technologies, Inc.
 Genelabs Technologies, Inc. Pharmaceuticals: MajorHealth Technology Genelabs Technologies, Inc. discovery and development of pharmaceutical products to improve human health. The company was founded by Brian D. Frenzel and Frank C. Kung in 1983 and is headquartered in Redwood, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Chairman Director/Board Member Director of Finance/CFO | |
| University of Cambridge | College/University | Corporate Officer/Principal Doctorate Degree Doctorate Degree Undergraduate Degree Doctorate Degree Undergraduate Degree | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| University of Oxford | College/University | Doctorate Degree Director/Board Member Undergraduate Degree Doctorate Degree Doctorate Degree | |
POINT Biopharma Corp.
 POINT Biopharma Corp. Miscellaneous Commercial ServicesCommercial Services Part of POINT Biopharma Global, Inc., POINT Biopharma Corp. is a Canadian company that develops next-generation radiopharmaceuticals for the treatment of cancer. The company is based in Toronto, Canada. POINT Biopharma develops radioligands, which are microscopic, cancer-seeking missiles used to diagnose and treat cancers such as non-Hodgkin's lymphoma and neuroendocrine tumors (NETs). To learn more about the company, interested parties can register online at https\://hub.pointbiopharma.com/investor-day-june-2023. The company was founded by Joe McCann. Joe McCann has been the CEO since incorporation. | Miscellaneous Commercial Services | Chairman Director/Board Member Chief Tech/Sci/R&D Officer Founder | |
| DICE THER | Biotechnology | President Director/Board Member Director/Board Member Corporate Secretary | |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
| University of Bristol | College/University | Undergraduate Degree Doctorate Degree Doctorate Degree Doctorate Degree | |
Novartis Oncology, Inc.
 Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Novartis Oncology, Inc. provides healthcare solutions. The firm offers medicines, eye care and generic pharmaceuticals. It also offers patient declaration, patient support and assistance, and additional resources. The company is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO President Corporate Officer/Principal | |
| University of Toronto | College/University | Undergraduate Degree Corporate Officer/Principal Undergraduate Degree Corporate Officer/Principal | |
| University of Wisconsin | College/University | Corporate Officer/Principal Masters Business Admin Doctorate Degree | |
| BP PLC | Integrated Oil | Director/Board Member Director/Board Member Director/Board Member | |
| MERUS N.V. | Biotechnology | Director/Board Member Chairman Director/Board Member | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
The University of Liverpool
 The University of Liverpool Other Consumer ServicesConsumer Services The University of Liverpool operates as a university. It offers post graduate research, foundation courses, continuing and professional development, online study, and doctoral college. The company was founded in 1881 and is headquartered in Liverpool, the United Kingdom. | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| The Trustees of Columbia University in The City of New York | College/University | Masters Business Admin Graduate Degree Corporate Officer/Principal | |
| SIGILON THERAPEUTICS, INC. | Biotechnology | President Director/Board Member Corporate Secretary | |
| Stanford University | College/University | Masters Business Admin Corporate Officer/Principal Doctorate Degree | |
| University of the Sciences in Philadelphia | College/University | Undergraduate Degree Director/Board Member Undergraduate Degree | |
| ACHILLION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director/Board Member Chief Tech/Sci/R&D Officer | |
| University of London | College/University | Undergraduate Degree Doctorate Degree Doctorate Degree | |
Human Genome Sciences, Inc.
 Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Medical Specialties | Director/Board Member Chairman Chief Tech/Sci/R&D Officer | |
Bausch Health Americas, Inc.
 Bausch Health Americas, Inc. Pharmaceuticals: MajorHealth Technology Bausch Health Americas, Inc. manufactures and distributes pharmaceutical products. The company was founded on November 29, 2011 and is headquartered in Bridgewater, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member Sales & Marketing | |
GSK Equity Investments Ltd.
 GSK Equity Investments Ltd. Investment ManagersFinance GSK Equity Investment Ltd (GSK Equity) is a venture capital firm a subsidiary of GlaxoSmithKline Plc founded in 1985. The firm is headquartered in Reedwood City, California. | Investment Managers | Private Equity Investor President President | |
| University of Michigan | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Janssen Pharmaceuticals, Inc.
 Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Pharmaceuticals: Major | President Corporate Officer/Principal Sales & Marketing | |
VectivBio AG
 VectivBio AG BiotechnologyHealth Technology VectivBio AG is a clinical-stage biotechnology company. The firm focuses on developing transformational therapeutics for patients living with serious and rare diseases. Its program apraglutide, is a next-generation GLP-2 analog for the treatment of short bowel syndrome (SBS). The company was founded by Luca Santarelli in 2019 and is headquartered in Basel, Switzerland. | Biotechnology | Director/Board Member Director/Board Member | |
| RADIUS HEALTH, INC. | Biotechnology | Director/Board Member Chairman | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Investor Relations Contact Corporate Officer/Principal | |
Novartis Corp.
 Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO | |
| Yale School of Medicine | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
| ABLYNX | Biotechnology | Chairman Chief Tech/Sci/R&D Officer | |
| JAZZ PHARMACEUTICALS PLC | Pharmaceuticals: Major | Director of Finance/CFO Chief Operating Officer | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
| University of Illinois | College/University | Undergraduate Degree Undergraduate Degree | |
| The University of Southampton | College/University | Doctorate Degree Doctorate Degree | |
| The University of Manchester | College/University | Doctorate Degree Undergraduate Degree | |
| CELLECTIS S.A. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| North Carolina State University | College/University | Doctorate Degree Undergraduate Degree | |
NormOxys, Inc.
 NormOxys, Inc. Pharmaceuticals: MajorHealth Technology NormOxys, Inc. develops small-molecule therapeutics for the treatment of cancer. Its major product is OXY111A. The company was founded by Conrad J Bletzer, Jr. Claude Nicoalu, Jean-Mearie Lehn, Gay Goodman, Ruth Greferath and Roscoe Brady in 2004 and is headquartered in Brighton, MA. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| ABBOTT LABORATORIES | Medical Specialties | Director/Board Member Corporate Officer/Principal | |
| Iowa State University | College/University | Undergraduate Degree Undergraduate Degree | |
| Philadelphia College of Osteopathic Medicine | College/University | Doctorate Degree Corporate Officer/Principal | |
| Boston University | College/University | Graduate Degree Graduate Degree | |
| INTERMUNE INC | Biotechnology | Chief Tech/Sci/R&D Officer Sales & Marketing |
Statistics
International
| United States | 33 |
| United Kingdom | 10 |
| Canada | 3 |
| Switzerland | 3 |
| Netherlands | 2 |
Sectoral
| Health Technology | 26 |
| Consumer Services | 21 |
| Commercial Services | 4 |
| Energy Minerals | 2 |
| Finance | 2 |
Operational
| Director/Board Member | 500 |
| Corporate Officer/Principal | 244 |
| Independent Dir/Board Member | 180 |
| Chairman | 156 |
| Chief Tech/Sci/R&D Officer | 94 |
Most connected contacts
| Insiders | |
|---|---|
| Argeris Karabelas | 42 |
| Tamar Howson | 41 |
| Richard Sykes | 37 |
| Russell Greig | 31 |
| David Epstein | 29 |
| Jean-Pierre Garnier | 28 |
| Faheem Hasnain | 27 |
| Deryck Charles Maughan | 27 |
| Mark Iwicki | 26 |
| Jonathan Goodman | 25 |
| Maxine Gowen | 23 |
| H. Culp | 21 |
| George Poste | 21 |
| Michael Owen | 20 |
| Crispin Davis | 20 |
- Stock Market
- Insiders
- Myra Rosario Herrle
- Company connections
